LivaNova PLC Restructuring and Related Cost, Cost Incurred to Date
LivaNova PLC (LIVN) had Restructuring and Related Cost, Cost Incurred to Date of $136.40 million as of 2023-12-31, per its 10-K filed 2024-02-29.
Discontinued › Notes
us-gaap:RestructuringAndRelatedCostCostIncurredToDate1 · last filed 2024-02-29
- 2023-12-31: Restructuring and Related Cost, Cost Incurred to Date $136.40M.
- 2022-12-31: Restructuring and Related Cost, Cost Incurred to Date $135.40M.
- 2021-12-31: Restructuring and Related Cost, Cost Incurred to Date $128.80M.
- 2020-12-31: Restructuring and Related Cost, Cost Incurred to Date $119.10M.
| Period end | Restructuring and Related Cost, Cost Incurred to Date |
|---|---|
| 2023-12-31 | $136.40M 10-K · filed 2024-02-29 |
| 2022-12-31 | $135.40M 10-K · filed 2023-02-27 |
| 2021-12-31 | $128.80M 10-K · filed 2022-03-01 |
| 2020-12-31 | $119.10M 10-K · filed 2021-03-01 |
| 2020-03-31 | $113.10M 10-Q · filed 2020-04-30 |
| 2019-12-31 | $111.50M 10-K · filed 2020-03-02 |
| 2018-12-31 | $99.30M 10-K · filed 2019-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Integer Holdings Corp (ITGR) | United States | $4.289B | 25.17 |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |